The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 517,980 | 44,500 | SH | SOLE | 44,500 | 0 | 0 | ||
AGENUS INC | COM NEW | 00847G705 | 272,368 | 469,600 | SH | SOLE | 469,600 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 441,524 | 15,100 | SH | SOLE | 15,100 | 0 | 0 | ||
AIRSPAN NETWORKS HOLDINGS IN | COM | 00951K104 | 118,364 | 1,047,473 | SH | SOLE | 1,047,473 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 234,486 | 186,100 | SH | SOLE | 186,100 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 573,948 | 128,400 | SH | SOLE | 128,400 | 0 | 0 | ||
ALLOVIR INC | COM | 019818103 | 162,832 | 215,700 | SH | SOLE | 215,700 | 0 | 0 | ||
ALPHABET INC | CAP STK CL A | 02079K305 | 30,035,070 | 199,000 | SH | SOLE | 199,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 1,117,764 | 109,800 | SH | SOLE | 109,800 | 0 | 0 | ||
AMAZON COM INC | COM | 023135106 | 53,392,480 | 296,000 | SH | SOLE | 296,000 | 0 | 0 | ||
ANTERO RESOURCES CORP | COM | 03674X106 | 14,500,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
ANTERO RESOURCES CORP | COM | 03674X106 | 32,857,000 | 1,133,000 | SH | SOLE | 1,133,000 | 0 | 0 | ||
APPLE INC | COM | 037833100 | 27,436,800 | 160,000 | SH | Put | SOLE | 160,000 | 0 | 0 | |
ARCTURUS THERAPEUTICS HLDGS | COM | 03969T109 | 442,387 | 13,100 | SH | SOLE | 13,100 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 447,456 | 23,700 | SH | SOLE | 23,700 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 1,693,619 | 170,900 | SH | SOLE | 170,900 | 0 | 0 | ||
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 236,598 | 83,900 | SH | SOLE | 83,900 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 111,872 | 87,400 | SH | SOLE | 87,400 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 401,759 | 168,100 | SH | SOLE | 168,100 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 394,020 | 199,000 | SH | SOLE | 199,000 | 0 | 0 | ||
ECHOSTAR CORP | CL A | 278768106 | 30,683,228 | 2,153,209 | SH | SOLE | 2,153,209 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 612,846 | 35,100 | SH | SOLE | 35,100 | 0 | 0 | ||
ENOVIS CORPORATION | COM | 194014502 | 24,980,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 342,372 | 166,200 | SH | SOLE | 166,200 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 1,072,374 | 146,100 | SH | SOLE | 146,100 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 1,805,740 | 768,400 | SH | SOLE | 768,400 | 0 | 0 | ||
GETAROUND INC | COM | 37427G101 | 413,883 | 1,348,153 | SH | SOLE | 1,348,153 | 0 | 0 | ||
GRAB HOLDINGS LIMITED | *W EXP 99/99/999 | G4124C117 | 16,208 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 626,285 | 64,900 | SH | SOLE | 64,900 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 644,736 | 43,800 | SH | SOLE | 43,800 | 0 | 0 | ||
MICRON TECHNOLOGY INC | COM | 595112103 | 36,074,340 | 306,000 | SH | SOLE | 306,000 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 47,120,640 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 288,234 | 60,300 | SH | SOLE | 60,300 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 834,960 | 56,800 | SH | SOLE | 56,800 | 0 | 0 | ||
PERIMETER SOLUTIONS SA | COMMON STOCK | L7579L106 | 17,066,000 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 351,920 | 42,400 | SH | SOLE | 42,400 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 249,185 | 30,500 | SH | SOLE | 30,500 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 327,950 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 226,269 | 292,300 | SH | SOLE | 292,300 | 0 | 0 | ||
THE ODP CORP | COM | 88337F105 | 21,220,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
TRANSDIGM GROUP INC | COM | 893641100 | 51,727,200 | 42,000 | SH | SOLE | 42,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 430,218 | 55,800 | SH | SOLE | 55,800 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 252,200 | 48,500 | SH | SOLE | 48,500 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 510,624 | 32,400 | SH | SOLE | 32,400 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985Y108 | 407,124 | 38,700 | SH | SOLE | 38,700 | 0 | 0 |